SLC41A2
gene geneOn this page
Also known as DKFZP434K0427
Summary
SLC41A2 (solute carrier family 41 member 2, HGNC:31045) is a protein-coding gene on chromosome 12q23.3, encoding Solute carrier family 41 member 2 (Q96JW4). Acts as a plasma-membrane magnesium transporter.
Predicted to enable magnesium ion transmembrane transporter activity. Involved in magnesium ion transport. Located in plasma membrane.
Source: NCBI Gene 84102 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 97 total
- MANE Select transcript:
NM_001352171
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31045 |
| Approved symbol | SLC41A2 |
| Name | solute carrier family 41 member 2 |
| Location | 12q23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZP434K0427 |
| Ensembl gene | ENSG00000136052 |
| Ensembl biotype | protein_coding |
| OMIM | 610802 |
| Entrez | 84102 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 18 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000258538, ENST00000411411, ENST00000415674, ENST00000417469, ENST00000424946, ENST00000432951, ENST00000433540, ENST00000437220, ENST00000449866, ENST00000549713, ENST00000906846, ENST00000906847, ENST00000906848, ENST00000906849, ENST00000906850, ENST00000906851, ENST00000906852, ENST00000906853, ENST00000963050
RefSeq mRNA: 11 — MANE Select: NM_001352171
NM_001352169, NM_001352170, NM_001352171, NM_001352172, NM_001387125, NM_001387126, NM_001387127, NM_001387128, NM_001387129, NM_001387130, NM_032148
CCDS: CCDS9100
Canonical transcript exons
ENST00000258538 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000922975 | 104845843 | 104845974 |
| ENSE00000922976 | 104861291 | 104861370 |
| ENSE00000922978 | 104886293 | 104886439 |
| ENSE00000922980 | 104895274 | 104895345 |
| ENSE00000922981 | 104909655 | 104909762 |
| ENSE00000937858 | 104866432 | 104866579 |
| ENSE00000937859 | 104844472 | 104844620 |
| ENSE00001255321 | 104927973 | 104928694 |
| ENSE00001650772 | 104801801 | 104805337 |
| ENSE00003790761 | 104889033 | 104889177 |
| ENSE00003916167 | 104958088 | 104958290 |
Expression profiles
Bgee: expression breadth ubiquitous, 226 present calls, max score 95.00.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.0878 / max 147.2639, expressed in 1371 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 133019 | 6.8426 | 1253 |
| 133020 | 1.2452 | 649 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 95.00 | gold quality |
| jejunal mucosa | UBERON:0000399 | 94.73 | gold quality |
| secondary oocyte | CL:0000655 | 93.20 | gold quality |
| ileal mucosa | UBERON:0000331 | 92.94 | gold quality |
| duodenum | UBERON:0002114 | 92.56 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 92.45 | gold quality |
| colonic epithelium | UBERON:0000397 | 92.45 | gold quality |
| liver | UBERON:0002107 | 92.38 | gold quality |
| right lobe of liver | UBERON:0001114 | 91.60 | gold quality |
| islet of Langerhans | UBERON:0000006 | 90.32 | gold quality |
| adrenal tissue | UBERON:0018303 | 90.22 | gold quality |
| parotid gland | UBERON:0001831 | 88.41 | gold quality |
| corpus epididymis | UBERON:0004359 | 88.20 | gold quality |
| cartilage tissue | UBERON:0002418 | 88.00 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 87.90 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 87.61 | gold quality |
| rectum | UBERON:0001052 | 86.68 | gold quality |
| pancreas | UBERON:0001264 | 86.67 | gold quality |
| stomach | UBERON:0000945 | 86.59 | gold quality |
| sperm | CL:0000019 | 86.54 | gold quality |
| colonic mucosa | UBERON:0000317 | 86.29 | gold quality |
| body of stomach | UBERON:0001161 | 86.26 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 85.73 | gold quality |
| thoracic aorta | UBERON:0001515 | 85.71 | gold quality |
| ascending aorta | UBERON:0001496 | 85.52 | gold quality |
| gall bladder | UBERON:0002110 | 85.49 | gold quality |
| tendon | UBERON:0000043 | 85.19 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 85.12 | gold quality |
| body of pancreas | UBERON:0001150 | 84.74 | gold quality |
| seminal vesicle | UBERON:0000998 | 83.83 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.39 |
| E-MTAB-8498 | yes | 9.15 |
| E-MTAB-2983 | no | 479.94 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
96 targeting SLC41A2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-3617-3P | 99.98 | 67.86 | 918 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-4487 | 99.96 | 64.58 | 1252 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc41a2b | ENSDARG00000073881 |
| danio_rerio | slc41a2a | ENSDARG00000075803 |
| mus_musculus | Slc41a2 | ENSMUSG00000034591 |
| rattus_norvegicus | Slc41a2 | ENSRNOG00000008713 |
| drosophila_melanogaster | CG33181 | FBGN0053181 |
| caenorhabditis_elegans | ZK1053.6 | WBGENE00014201 |
| caenorhabditis_elegans | WBGENE00019504 | |
| caenorhabditis_elegans | WBGENE00022682 |
Paralogs (2): SLC41A3 (ENSG00000114544), SLC41A1 (ENSG00000133065)
Protein
Protein identifiers
Solute carrier family 41 member 2 — Q96JW4 (reviewed: Q96JW4)
All UniProt accessions (9): C9J2P6, C9JA64, C9JCR2, C9JDQ2, Q96JW4, C9JIL4, C9JKF2, C9JYJ7, H7BZT9
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a plasma-membrane magnesium transporter. Can also mediate the transport of other divalent metal cations in an order of Ba(2+) > Ni(2+) > Co(2+) > Fe(2+) > Mn(2+).
Subcellular location. Cell membrane.
Similarity. Belongs to the SLC41A transporter family.
RefSeq proteins (11): NP_001339098, NP_001339099, NP_001339100, NP_001339101, NP_001374054, NP_001374055, NP_001374056, NP_001374057, NP_001374058, NP_001374059, NP_115524 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006667 | SLC41_membr_dom | Domain |
| IPR036739 | SLC41_membr_dom_sf | Homologous_superfamily |
| IPR045349 | SLC41A1-3 | Family |
Pfam: PF01769
Catalyzed reactions (Rhea), 5 shown:
- Fe(2+)(in) = Fe(2+)(out) (RHEA:28486)
- Co(2+)(in) = Co(2+)(out) (RHEA:28578)
- Mn(2+)(in) = Mn(2+)(out) (RHEA:28699)
- Mg(2+)(in) = Mg(2+)(out) (RHEA:29827)
- Ni(2+)(in) = Ni(2+)(out) (RHEA:29831)
UniProt features (27 total): topological domain 12, transmembrane region 11, modified residue 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96JW4-F1 | 72.69 | 0.39 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 136, 137
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-425410 | Metal ion SLC transporters |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-425366 | |
| R-HSA-425407 | SLC-mediated transmembrane transport |
MSigDB gene sets: 184 (showing top):
GOBP_TRANSITION_METAL_ION_TRANSPORT, GOBP_MAGNESIUM_ION_TRANSPORT, GOBP_IRON_ION_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, AAACCAC_MIR140, TCF11_01, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5, TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P, GOBP_TRANSMEMBRANE_TRANSPORT, PITX2_Q2, HOWLIN_CITED1_TARGETS_2_DN, MASSARWEH_TAMOXIFEN_RESISTANCE_UP, GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, chr12q23
GO Biological Process (11): cobalt ion transport (GO:0006824), iron ion transport (GO:0006826), manganese ion transport (GO:0006828), nickel cation transport (GO:0015675), magnesium ion transport (GO:0015693), monoatomic ion transport (GO:0006811), monoatomic cation transport (GO:0006812), metal ion transport (GO:0030001), transmembrane transport (GO:0055085), monoatomic cation transmembrane transport (GO:0098655), magnesium ion transmembrane transport (GO:1903830)
GO Molecular Function (4): magnesium ion transmembrane transporter activity (GO:0015095), protein binding (GO:0005515), monoatomic cation transmembrane transporter activity (GO:0008324), obsolete inorganic cation transmembrane transporter activity (GO:0022890)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| SLC-mediated transmembrane transport | 1 |
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transition metal ion transport | 4 |
| monoatomic cation transmembrane transport | 3 |
| transport | 2 |
| monoatomic cation transport | 2 |
| metal ion transport | 1 |
| monoatomic ion transport | 1 |
| cellular process | 1 |
| monoatomic ion transmembrane transport | 1 |
| magnesium ion transport | 1 |
| metal ion transmembrane transporter activity | 1 |
| magnesium ion transmembrane transport | 1 |
| binding | 1 |
| monoatomic ion transmembrane transporter activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
612 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC41A2 | TRPM6 | Q9BX84 | 755 |
| SLC41A2 | TRPM7 | Q96QT4 | 737 |
| SLC41A2 | MRS2 | Q9HD23 | 692 |
| SLC41A2 | CNNM2 | Q9H8M5 | 671 |
| SLC41A2 | MAGT1 | Q9H0U3 | 616 |
| SLC41A2 | CNNM1 | Q9NRU3 | 598 |
| SLC41A2 | NIPAL3 | Q6P499 | 507 |
| SLC41A2 | CNNM3 | Q8NE01 | 498 |
| SLC41A2 | NIPA1 | Q7RTP0 | 495 |
| SLC41A2 | CNNM4 | Q6P4Q7 | 477 |
| SLC41A2 | SLC35H1 | Q9NQQ7 | 474 |
| SLC41A2 | NIPAL1 | Q6NVV3 | 467 |
| SLC41A2 | CLDN16 | Q9Y5I7 | 461 |
| SLC41A2 | NIPA2 | Q8N8Q9 | 460 |
| SLC41A2 | SLC38A6 | Q8IZM9 | 458 |
IntAct
101 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC41A2 | KASH5 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KASH5 | SLC41A2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| SLC41A2 | HHLA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC41A2 | AMIGO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC41A2 | SLC6A15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC41A2 | SHISAL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC41A2 | GPR42 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC41A2 | LYVE1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SSMEM1 | SLC41A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC41A2 | MFF | psi-mi:“MI:0915”(physical association) | 0.560 |
| FATE1 | SLC41A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LDLRAD1 | SLC41A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IGFBP5 | SLC41A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FUT3 | SLC41A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLN5 | SLC41A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PVR | SLC41A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ERVFRD-1 | SLC41A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SHISAL1 | SLC41A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LEUTX | SLC41A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (43): CCDC155 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Synthetic Lethality), SLC41A2 (Affinity Capture-RNA), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), KIAA1644 (Two-hybrid)
ESM2 similar proteins: A0A2K1ZPK4, A0A2K2AIF4, A0A2K2BF92, B9GNS0, B9H7I1, E7EXX2, O22881, O54902, O77741, P41251, P49279, P49280, P49281, P49282, P49283, P51027, P56436, P70553, Q0D7E4, Q21433, Q21434, Q27946, Q27981, Q4R335, Q5QN13, Q5ZHX6, Q6DFC0, Q6DIV6, Q6PF45, Q6YWQ4, Q6ZG85, Q7XIV8, Q869V1, Q8BGY9, Q8BYR8, Q8H3P9, Q8H4H5, Q8UWF0, Q8VDT1, Q8VXB5
Diamond homologs: E7EXX2, Q3SWT5, Q4R335, Q5R839, Q5ZHX6, Q6DFC0, Q8BJA2, Q8BYR8, Q8IVJ1, Q921R8, Q96GZ6, Q96JW4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
97 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 59 |
| Likely benign | 1 |
| Benign | 24 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1760 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:104861366:CAATG:C | acceptor_gain | 1.0000 |
| 12:104861369:TG:T | acceptor_gain | 1.0000 |
| 12:104909653:A:AC | donor_gain | 1.0000 |
| 12:104909654:C:CC | donor_gain | 1.0000 |
| 12:104909654:CTG:C | donor_gain | 1.0000 |
| 12:104909654:CTGCA:C | donor_gain | 1.0000 |
| 12:104927970:CA:C | donor_loss | 1.0000 |
| 12:104927971:A:AT | donor_loss | 1.0000 |
| 12:104844530:C:CT | donor_gain | 0.9900 |
| 12:104844618:CTC:C | acceptor_gain | 0.9900 |
| 12:104845837:ACAT:A | donor_loss | 0.9900 |
| 12:104845838:CATA:C | donor_loss | 0.9900 |
| 12:104845840:TA:T | donor_loss | 0.9900 |
| 12:104845841:ACC:A | donor_loss | 0.9900 |
| 12:104845842:C:CG | donor_loss | 0.9900 |
| 12:104845971:ATACC:A | acceptor_loss | 0.9900 |
| 12:104845972:TAC:T | acceptor_gain | 0.9900 |
| 12:104845972:TACC:T | acceptor_loss | 0.9900 |
| 12:104845973:ACCTG:A | acceptor_loss | 0.9900 |
| 12:104845974:CCTGA:C | acceptor_loss | 0.9900 |
| 12:104845975:C:A | acceptor_loss | 0.9900 |
| 12:104845976:T:A | acceptor_loss | 0.9900 |
| 12:104861285:TCTTA:T | donor_loss | 0.9900 |
| 12:104861286:CT:C | donor_loss | 0.9900 |
| 12:104861287:TTA:T | donor_loss | 0.9900 |
| 12:104861288:TACC:T | donor_loss | 0.9900 |
| 12:104861289:A:AC | donor_gain | 0.9900 |
| 12:104861289:A:C | donor_loss | 0.9900 |
| 12:104861290:C:CC | donor_gain | 0.9900 |
| 12:104861367:AATG:A | acceptor_gain | 0.9900 |
AlphaMissense
3754 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:104805225:C:T | G550E | 1.000 |
| 12:104805226:C:A | G550W | 1.000 |
| 12:104805226:C:G | G550R | 1.000 |
| 12:104805226:C:T | G550R | 1.000 |
| 12:104805234:T:G | D547A | 1.000 |
| 12:104805249:A:G | L542P | 1.000 |
| 12:104845929:G:A | T434I | 1.000 |
| 12:104845938:C:A | R431M | 1.000 |
| 12:104845940:G:C | S430R | 1.000 |
| 12:104845940:G:T | S430R | 1.000 |
| 12:104845942:T:G | S430R | 1.000 |
| 12:104845961:A:C | N423K | 1.000 |
| 12:104845961:A:T | N423K | 1.000 |
| 12:104861353:A:G | L398P | 1.000 |
| 12:104866447:G:T | A387D | 1.000 |
| 12:104866466:A:G | W381R | 1.000 |
| 12:104866466:A:T | W381R | 1.000 |
| 12:104886348:G:C | D324E | 1.000 |
| 12:104886348:G:T | D324E | 1.000 |
| 12:104886349:T:A | D324V | 1.000 |
| 12:104886349:T:C | D324G | 1.000 |
| 12:104886349:T:G | D324A | 1.000 |
| 12:104886350:C:G | D324H | 1.000 |
| 12:104886352:C:A | G323V | 1.000 |
| 12:104886352:C:T | G323D | 1.000 |
| 12:104886353:C:A | G323C | 1.000 |
| 12:104886353:C:G | G323R | 1.000 |
| 12:104886357:A:C | S321R | 1.000 |
| 12:104886357:A:T | S321R | 1.000 |
| 12:104886359:T:G | S321R | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000005611 (12:104928784 AAC>A), RS1000013041 (12:104831738 T>C), RS1000015644 (12:104835252 T>C), RS1000067864 (12:104834950 T>G), RS1000082940 (12:104842494 T>A), RS1000093863 (12:104889737 G>A,C), RS1000157100 (12:104956553 C>A), RS1000157860 (12:104921987 T>A), RS1000163075 (12:104805707 A>C), RS1000168948 (12:104864846 C>G), RS1000248494 (12:104958265 T>C), RS1000280241 (12:104951544 A>G), RS1000319081 (12:104903907 A>G), RS1000323053 (12:104816025 G>C), RS1000364234 (12:104949810 C>T)
Disease associations
OMIM: gene MIM:610802 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010923_11 | Beta blocker survival benefit in heart failure with reduced ejection fraction (time to all cause mortality x beta blocker interaction) | 8.000000e-06 |
| GCST011998_10 | Glucocorticoid receptor gene expression in B-cell precursor acute lymphoblastic leukaemia | 9.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004352 | mortality |
| EFO:0007766 | response to beta blocker |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC41 family of divalent cation transporters
CTD chemical–gene interactions
44 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, affects expression, decreases methylation | 6 |
| sodium arsenite | decreases expression, affects cotreatment, increases abundance, increases expression | 3 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 2 |
| Cyclosporine | increases expression | 2 |
| Aflatoxin B1 | decreases expression, decreases methylation | 2 |
| aristolochic acid I | decreases expression | 1 |
| bisphenol A | increases expression | 1 |
| trichostatin A | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| manganese chloride | increases expression, affects cotreatment, increases abundance | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| chromium hexavalent ion | decreases expression | 1 |
| entinostat | increases expression | 1 |
| dimethylarsinous acid | increases expression | 1 |
| 2,2’,4,4’,5-brominated diphenyl ether | increases expression | 1 |
| 3,4,5,4’-tetramethoxystilbene | affects expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Calcitriol | increases expression, affects cotreatment | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Lead | affects expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4NY | HCT116-SLC41A2-KO-c4 | Cancer cell line | Male |
| CVCL_D4NZ | HCT116-SLC41A2-KO-c6 | Cancer cell line | Male |
| CVCL_TN67 | HAP1 SLC41A2 (-) | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.